Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,375,709 papers from all fields of science
Search
Sign In
Create Free Account
vaccine adjuvant
Known as:
adjuvants vaccine
A substance added to a vaccine to improve the immune response so that less vaccine is needed.
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Interleukin-21 and cellular activation concurrently induce potent cytotoxic function and promote antiviral activity in human CD8 T cells.
A. Parmigiani
,
Maria F. Pallin
,
H. Schmidtmayerova
,
M. Lichtenheld
,
S. Pahwa
Human Immunology
2011
Corpus ID: 23751667
2007
2007
Act1-ivating IL-17 inflammation
C. Hunter
Nature Immunology
2007
Corpus ID: 11835718
The signaling adaptor Act1 is now shown in vivo to be essential for interleukin 17–mediated inflammation in the brain during…
Expand
2006
2006
A soluble LAG-3 protein as an immunopotentiator for therapeutic vaccines: Preclinical evaluation of IMP321.
S. Fougeray
,
C. Brignone
,
F. Triebel
Vaccine
2006
Corpus ID: 8499378
Highly Cited
2004
Highly Cited
2004
Co-immunization with plasmid IL-12 generates a strong T-cell memory response in mice.
M. Chattergoon
,
Vera Saulino
,
Jason Shames
,
Jamie Stein
,
L. Montaner
,
D. Weiner
Vaccine
2004
Corpus ID: 2993702
Review
2004
Review
2004
From toxin to adjuvant: the rational design of a vaccine adjuvant vector, CTA1‐DD/ISCOM
N. Lycke
Cellular Microbiology
2004
Corpus ID: 20467512
Mucosally active vaccine adjuvants which will prime a full range of local and systemic immune responses against defined antigenic…
Expand
Review
2003
Review
2003
Vaccine adjuvant technology: from mechanistic concepts to practical applications
W. G. Degen
,
T. Jansen
,
V. Schijns
Expert Review of Vaccines
2003
Corpus ID: 41237731
Distinct types of immune responses are required for efficient elimination of different pathogens. Programming of the desired type…
Expand
Review
2001
Review
2001
Modulation of host responses to blood-stage malaria by interleukin-12: from therapy to adjuvant activity.
M. M. Stevenson
,
Zhong Su
,
Hakeem Sam
,
Karkada Mohan
Microbes and infection
2001
Corpus ID: 1657899
Highly Cited
1999
Highly Cited
1999
IL‐12 is a potent neonatal vaccine adjuvant
B. Arulanandam
,
V. Van Cleave
,
D. Metzger
European Journal of Immunology
1999
Corpus ID: 11437102
Neonatal animals show generally poor responsiveness to foreign antigens and are known to display polarized expression of Th2‐like…
Expand
Highly Cited
1999
Highly Cited
1999
Potent activity of soluble B7-IgG fusion proteins in therapy of established tumors and as vaccine adjuvant.
K. Sturmhoefel
,
Kwang Lee
,
+6 authors
Stanley F. Wolf
Cancer Research
1999
Corpus ID: 7917583
Fusion proteins consisting of the extracellular region of murine B7.1 or B7.2 and the Fc portion of murine IgG2a (B7-IgG) were…
Expand
Highly Cited
1998
Highly Cited
1998
Prevention of Peripheral Tolerance by a Dendritic Cell Growth Factor: Flt3 Ligand as an Adjuvant
B. Pulendran
,
B. Pulendran
,
+4 authors
C. Maliszewski
Journal of Experimental Medicine
1998
Corpus ID: 16766052
Injections of soluble proteins are poorly immunogenic, and often elicit antigen-specific tolerance. The mechanism of this…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE